First Tracks Biotherapeutics, spun off from AnaptysBio, launches with $180M cash and a diverse, early-stage pipeline. Read ...

Defined by ambition and often motivated by war, these programs include some pretty unique designs.

Artiva Biotherapeutics (ARTV) is maintained as a "Buy," driven by FDA alignment for a single phase 3 trial of AlloNK plus ...

Confronted with public controversy surrounding insider trading in prediction markets, the United States Senate has taken action both ...

Background Persistent shockable rhythms (refractory to or recurring after three or more defibrillation attempts) are ...

This paper examines whether biological age, as distinct from chronological age, could become a new basis for discrimination.

Success is less about memorizing formulas and more about understanding process behavior, valves, operators and controller ...

Declined to $795 million, as backlog normalization and a market shift to lighter-duty, lower-priced trucks reduced average ...

The CFTC just closed comments on prediction markets. Over 1,500 people weighed in. And the split’s pretty stark—some want ...

Bitcoin volatility halved to 40.7% in April 2026, threatening the $81B crypto-casino industry as Stake.com hedges and ...

The payout comes after the aviation giant reported its highest-ever profit, revenue and cash balances despite operational ...

David Toro-Tobon and colleagues argue that “clinician in the loop” is shifting responsibility for AI safety from developers ...